CA2200764C - Soft-ended fibered micro vaso-occlusive devices - Google Patents
Soft-ended fibered micro vaso-occlusive devices Download PDFInfo
- Publication number
- CA2200764C CA2200764C CA002200764A CA2200764A CA2200764C CA 2200764 C CA2200764 C CA 2200764C CA 002200764 A CA002200764 A CA 002200764A CA 2200764 A CA2200764 A CA 2200764A CA 2200764 C CA2200764 C CA 2200764C
- Authority
- CA
- Canada
- Prior art keywords
- retainer
- fibers
- coil
- vaso
- multiplicity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/008—Strength or flexibility characteristics of the catheter tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12159—Solid plugs; being solid before insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/008—Strength or flexibility characteristics of the catheter tip
- A61M2025/0081—Soft tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
Abstract
This is a micro-vaso-occlusive device intended generally for occlusion of small arteries located distally in the vasculature. The device is made up of a binder, often radio-opaque, which may be short in length by comparison to the length of the included thrombogenic fibers. The fibers form the other portion of the device. At least one end of the device includes a solid but comparatively soft end typically made of a molten mass of the fibers. The micro device may have multiple binder sections.
The fibers may be straight, looped, or tufted.
The fibers may be straight, looped, or tufted.
Description
- SOFT-ENDED FIBERED MICRO VASO-OCCLUSIVE DEVICES
Field of the Invention This invention is a surgical device. In particular, it is a micro-vaso occlusive device intended generally for occlusion of small arteries located s distally in the vasculature. The invention is made up of a binder, often radio-opaque, which may be short in length by comparison to the length of the included thrombogenic fibers. The fibers form the other portion of the device. At least one end of the device includes a solid but comparatively soft end typically made of a molten mass of the fibers. The micro device Io may have multiple'binder sections. The fibers may be straight, looped, or tufted.
Background of the Invention The use of occlusive devices in the vascular system and in other systems of the body, e.g., genito-urinary and biliary systems, is known..
is In the vasculature, a physician may apply a vaso-occlusive device using endovascular techniques to a selected site to cause the site to fill with thrombus. The occlusion often changes in composition to a more collagenous composition over time.
A variety of maladies may be treated in this way. For instance, an 20 occlusion may be used to limit bleeding due to vascular accidents such as strokes or to fill abnormal vascular cavities such as aneurysm or to limit the flow of blood to an anomalous anatomical region, e.g., a tumor or one of the extraneous sites in a multi-focal electrical arrhythmia.
Occlusive devices and materials used in such service are typically zs of two types: solids and reactive fluids. The class of solid-occlusive devices includes an eclectic variety of materials: hog hair, polyvinyl alcohol beads, collagen beads, latex beads, and silk or rayon fibers.
Devices such as coils or balloons are also known and used.
Cyanoacrylate glues are occasionally applied as vaso-occluding 3o materials. These are not type-approved and a specific approval must be determined for each use. Glues are difficult to place within the vasculature and although they create excellent occlusions, they may do so at a site downstream of the desired site.
The most practical of these devices and methods from both a precision placement aspect and an effectiveness aspect are vaso-occlusive coils with or without added thrombogenic fibers. An early endovascular coil device is found in Ritchart, et al., U.S. Patent No.
4,994,069. These devices are lengthy in comparison to the inventive devices described here and rely on the volume of the coil and the secondary shape of the coil after it exits the delivery catheter for defining the bulk of the resulting occlusion.
A variation of the vaso-occlusive coils are shown in U.S. Patent Nos. 5,226, 911 and 5,304,194 to Chee et. al. Those patents show the use of longer vaso-occlusive coils having attached fibrous elements which are looped from place-to-place along the coils.
A further variation is shown in U.S. Patent No. 5,382,259, to Phelps et. al. Phelps et al. shows a coil having a braided fibrous covering on the exterior of the coil. The braid is placed on the coil for the purpose of increasing the assembly's tendency to produce thrombus.
Target Therapeutics, Inc. owns other pending patent applications relating to vaso-occlusive devices including "FIBERED MICRO VASO-OCCLUSIVE DEVICES" by Sepetka et al., as described in Canadian Application No. 2,192,105 and "STRETCH RESISTANT VASO-OCCLUSIVE COILS" by Gia et al., as described in Canadian Application No. 2,191,780. Neither describes the devices claimed herein.
None of these devices are soft-ended, vaso-occlusive devices having short binders holding significantly longer fibers.
Other occluding devices having a plug-like form are known.
U.S. Patent No. 5,095,917, to Vancaille, shows a transuterine technique for sterilization of females using a biodegradable plug. The plug is used in conjunction with the destruction of a mucous layer to form ~~0~764 - a site for inflammation and, upon healing, form an occlusion. No fibers are used in conjunction with the plug.
U.S. Patent No. 5,192,301, to Kamiya et al., shows a closing plug which is to be delivered percutaneously to close somatic wall defects such s as arterial septal defects (ASD). The plug is preferably of a shape memory polymer and has shape involving a cone at one end and a flange at the other. Again, fibers are not involved in the structure of the device.
U.S. Patent No. 5,443, 478, to Purdy, shows a multi-element vascular device having an anchoring element and a lead element io connected by fibers. The anchoring element is typically a coil forming a circular element. After deployment of the device from a delivery catheter, the anchoring element secondary shape is approximately the size of the vessel to be occluded. The typically somewhat smaller lead element is also often a coil but is depicted to be of a smaller size than the anchoring Is element. The fibers are not aligned with the coil upon deployment of the device, however.
Japanese Kokai 4-312454 shows an occlusive device which appears to have multiple magnetic portions. The magnetic portions are shown to be square in Figure 1 and spherical in Figure 3 of the 2o publication. The magnetic portions do not appear to act as clasps on the fiber.
None of the disclosed devices are similar to the inventive vaso-occlusive device.
Summary of the Invention 2s This is a vaso-occlusive device made up of at least one short retainer, a longer fiber bundle, and at least one solid but soft end.. The retainer may be radio-opaque. The fibers may be straight, looped, or tufted. The primary use of the device is in the very small vessels at the distal portion of the vasculature.
Field of the Invention This invention is a surgical device. In particular, it is a micro-vaso occlusive device intended generally for occlusion of small arteries located s distally in the vasculature. The invention is made up of a binder, often radio-opaque, which may be short in length by comparison to the length of the included thrombogenic fibers. The fibers form the other portion of the device. At least one end of the device includes a solid but comparatively soft end typically made of a molten mass of the fibers. The micro device Io may have multiple'binder sections. The fibers may be straight, looped, or tufted.
Background of the Invention The use of occlusive devices in the vascular system and in other systems of the body, e.g., genito-urinary and biliary systems, is known..
is In the vasculature, a physician may apply a vaso-occlusive device using endovascular techniques to a selected site to cause the site to fill with thrombus. The occlusion often changes in composition to a more collagenous composition over time.
A variety of maladies may be treated in this way. For instance, an 20 occlusion may be used to limit bleeding due to vascular accidents such as strokes or to fill abnormal vascular cavities such as aneurysm or to limit the flow of blood to an anomalous anatomical region, e.g., a tumor or one of the extraneous sites in a multi-focal electrical arrhythmia.
Occlusive devices and materials used in such service are typically zs of two types: solids and reactive fluids. The class of solid-occlusive devices includes an eclectic variety of materials: hog hair, polyvinyl alcohol beads, collagen beads, latex beads, and silk or rayon fibers.
Devices such as coils or balloons are also known and used.
Cyanoacrylate glues are occasionally applied as vaso-occluding 3o materials. These are not type-approved and a specific approval must be determined for each use. Glues are difficult to place within the vasculature and although they create excellent occlusions, they may do so at a site downstream of the desired site.
The most practical of these devices and methods from both a precision placement aspect and an effectiveness aspect are vaso-occlusive coils with or without added thrombogenic fibers. An early endovascular coil device is found in Ritchart, et al., U.S. Patent No.
4,994,069. These devices are lengthy in comparison to the inventive devices described here and rely on the volume of the coil and the secondary shape of the coil after it exits the delivery catheter for defining the bulk of the resulting occlusion.
A variation of the vaso-occlusive coils are shown in U.S. Patent Nos. 5,226, 911 and 5,304,194 to Chee et. al. Those patents show the use of longer vaso-occlusive coils having attached fibrous elements which are looped from place-to-place along the coils.
A further variation is shown in U.S. Patent No. 5,382,259, to Phelps et. al. Phelps et al. shows a coil having a braided fibrous covering on the exterior of the coil. The braid is placed on the coil for the purpose of increasing the assembly's tendency to produce thrombus.
Target Therapeutics, Inc. owns other pending patent applications relating to vaso-occlusive devices including "FIBERED MICRO VASO-OCCLUSIVE DEVICES" by Sepetka et al., as described in Canadian Application No. 2,192,105 and "STRETCH RESISTANT VASO-OCCLUSIVE COILS" by Gia et al., as described in Canadian Application No. 2,191,780. Neither describes the devices claimed herein.
None of these devices are soft-ended, vaso-occlusive devices having short binders holding significantly longer fibers.
Other occluding devices having a plug-like form are known.
U.S. Patent No. 5,095,917, to Vancaille, shows a transuterine technique for sterilization of females using a biodegradable plug. The plug is used in conjunction with the destruction of a mucous layer to form ~~0~764 - a site for inflammation and, upon healing, form an occlusion. No fibers are used in conjunction with the plug.
U.S. Patent No. 5,192,301, to Kamiya et al., shows a closing plug which is to be delivered percutaneously to close somatic wall defects such s as arterial septal defects (ASD). The plug is preferably of a shape memory polymer and has shape involving a cone at one end and a flange at the other. Again, fibers are not involved in the structure of the device.
U.S. Patent No. 5,443, 478, to Purdy, shows a multi-element vascular device having an anchoring element and a lead element io connected by fibers. The anchoring element is typically a coil forming a circular element. After deployment of the device from a delivery catheter, the anchoring element secondary shape is approximately the size of the vessel to be occluded. The typically somewhat smaller lead element is also often a coil but is depicted to be of a smaller size than the anchoring Is element. The fibers are not aligned with the coil upon deployment of the device, however.
Japanese Kokai 4-312454 shows an occlusive device which appears to have multiple magnetic portions. The magnetic portions are shown to be square in Figure 1 and spherical in Figure 3 of the 2o publication. The magnetic portions do not appear to act as clasps on the fiber.
None of the disclosed devices are similar to the inventive vaso-occlusive device.
Summary of the Invention 2s This is a vaso-occlusive device made up of at least one short retainer, a longer fiber bundle, and at least one solid but soft end.. The retainer may be radio-opaque. The fibers may be straight, looped, or tufted. The primary use of the device is in the very small vessels at the distal portion of the vasculature.
y - Brief Description of the Drawings Figure 1 is a side view of a generalized version of the inventive vaso-occlusive device showing the conventions used in describing various aspects of the invention.
s Figure 2 shows a side cutaway view of a variation of the invention having a generally spherical binder.
Figure 3 shows a side cutaway view of a variation of the invention having a generally cylindrical binder.
Figure 4 shows a side cutaway view of a variation of the invention to having a coil as a binder.
Figure 5 shows a cutaway side view of a variation employing a coil retainer in which the fibers emanate from the side of the Retainer.
Figure 6 shows a cutaway side view of a variation using a coil retainer and an interior clip to retain the thrombogenic fibers.
is Figure 7A shows a side view cutaway of a variation of the invention having a ovoid binder and having passageways for the fiber element through the binder.
Figure 7B is an end cutaway view of the Figure 7A device.
Figure 8A is a side view of a device such as Figure 7A but having 2o multiple passageways.
Figure 8B is an end view of the Figure 8A device.
Figure 9 is a side view, partial cutaway of a variation of the invention having fibers on the exterior of the coil component.
Figure 10 is a side view, partial cutaway of a variation of the 2s invention having braided fibers on the exterior of the coil component.
Figure 11 is a side cutaway view of a multiple binder inventive device in which the fibers extend radially in the region between the binders.
Figures 12, 13, and 14 show a side cutaway view of a multiple 3o binder inventive device.
s Figure 2 shows a side cutaway view of a variation of the invention having a generally spherical binder.
Figure 3 shows a side cutaway view of a variation of the invention having a generally cylindrical binder.
Figure 4 shows a side cutaway view of a variation of the invention to having a coil as a binder.
Figure 5 shows a cutaway side view of a variation employing a coil retainer in which the fibers emanate from the side of the Retainer.
Figure 6 shows a cutaway side view of a variation using a coil retainer and an interior clip to retain the thrombogenic fibers.
is Figure 7A shows a side view cutaway of a variation of the invention having a ovoid binder and having passageways for the fiber element through the binder.
Figure 7B is an end cutaway view of the Figure 7A device.
Figure 8A is a side view of a device such as Figure 7A but having 2o multiple passageways.
Figure 8B is an end view of the Figure 8A device.
Figure 9 is a side view, partial cutaway of a variation of the invention having fibers on the exterior of the coil component.
Figure 10 is a side view, partial cutaway of a variation of the 2s invention having braided fibers on the exterior of the coil component.
Figure 11 is a side cutaway view of a multiple binder inventive device in which the fibers extend radially in the region between the binders.
Figures 12, 13, and 14 show a side cutaway view of a multiple 3o binder inventive device.
22007b4 - Description of the Invention The invention is a soft-tipped vaso-occlusive device typically made up of a number of components (which may be used in multiples): a retainer and a multiplicity of thrombogenic fibers, often in the form of a s bundle, and a soft tip on at least one end of the retainer. The retainer may also include a clip to hold the fibers.
Figure 1 shows in cross section a side view of a generalization of the inventive vaso-occlusive device (100). Figure 1 shows the convention and defines many of the specific terms used herein. The retainer or io binder (102) is so-called because in most variations of the inventions it retains the included fiber bundle (104) located in the passageway (106) located in retainer (102). The retainer (102) has a retainer length (108) which extends along the retainer axis (110) between the furthermost ends of the retainer (102). Similarly, the retainer (102) has a diameter (112) is which is the outer limit of the retainer (102) generally perpendicular to the axis (110). Desirable in this invention are retainers (102) in which the ratio of retainer length (108) to diameter (112) is no more than about two, preferably no more than about one. On at least one end of the retainer is a soft tip (114) which adheres to the retainer (102). The soft tip (114) may 2o be formed by application of heat to the fiber bundles and melting the fibers in the fiber bundle (104) to form a shaped tip. Of course, the tip may be formed by application of other materials (settable glues or caulks such as epoxies) or by melting another polymeric composition onto the tip region. By "soft tip", we mean that the hardness of the tip as measured by 2s accepted procedures (durometers, needle penetration, etc.) is less than the hardness of the helically wound coil itself.
The fiber portion (104) of the device (100) is a multiplicity of fibers having a length (114) which reflects the longest fiber extension in a specific device (100). Desirable to this invention are those structures in 3o which the ratio of the length (114) of the fibers (104) and the soft tip (114) to the retainer length (108) is at least two, more preferably at least five.
s Although the size of the device (100) is dependent upon the specific use to which it is placed, for most endovascular uses, the diameter (112) of retainer (102) typically will be between 0.005 and 0.090 inches. Smaller sizes are desirable because of the intent to use those devices in small, distal arteries. For that indication, a retainer outside diameter (112) of 0.005 to 0.015 inches is preferred.
The length (114) of the fibers are typically in the range of 0.100 inches or more.
The device (100) is typically radio-opaque. Either or both of the retainer (102) and the fibers (104) may be radio-opaque. The retainer (102) may be made of any material suitable for holding onto the fibers.
Typical materials include those metal or alloys selected from the group consisting of various stainless steels, gold, tungsten, platinum, palladium, rhodium, rhenium and alloys thereof. Preferred is an alloy of platinum and tungsten.
Other materials suitable for the retainer (102) include polymeric composition, e.g., adhesives and moldable caulks. Especially preferred are epoxies, urethane, and silicones. Highly desirable as adjuncts to these polymeric compositions are particulate radio-opaque fillers, e.g., powder tantalum, barium carbonate, bismuth oxide, barium sulfate, and the like.
The materials used in the fibers (104) may be thrombogenic material but typically are silk, cotton, polyesters such as the Nylons and polyethylene terephthalate (e.g., DACRON*), polyurethane, polyethylene, etc.
Figure 2 shows a side view, cross section of the inventive device (120) having a generally spherical retainer (122) and a soft end (123). In this variation, the passageway is an opening placed through the center of the retainer (122). The fibers (124) are held in place by, e.g., crimping or squeezing the retainer or by introducing a glue into the interior of the retainer. The fibers (124) are merely placed as tufts in the retainer (122).
*Trade-mark ~2(JU~~~
_i Figure 3 shows a side view cutaway of the device (126) in which the retainer (124) is generally cylindrical in shape. As was the case with the Figure 2 variation, the fibers (124) pass through the center of the retainer (128). A soft end is found at (125).
s Figure 4 shows a side view cutaway of a variation of the device (130) utilizing a coil as the retainer (132). When using high ductility metals in the coil retainer (132), it is sometimes desirable to augment the retainer (132) with a glue or the like to hold the fibers (124) with greater certainty. A soft tip (127)'is included on one end.
Figure 5 shows a side view cutaway of a variation of the device (131 ) utilizing coil (133) as the retainer. In this variation of the device, the fibers (134) do not pass completely through the axis of the retainer coil (133). Instead they are pulled through and are held in place by the coil itself after insertion between turns of the coil. The length of the various Is fibers (134) are much longer than is the length of coil (133). Typical of the use of a coil such as this in which the leading edge of the coil is exposed to the lumen of a blood vessel is the use of a rounded soft tip (135). Soft tip (135) may be made in a variety of different ways. The typical way of making such a tip is to melt a polymeric material onto the coil to form the 2o rounded tip (135). Although the diameter of tip (135) is shown to be relatively the same as that of coil (133), the rounded tip may have a diameter which is larger or smaller than coil (133).
Figure 6 shows still another variation of the vaso-occlusive device (136) utilizing a coil retainer (139). However, in this instance, the coil 2s (139) is used only as a portion of a retainer assembly. The device which directly encloses the fibers (143) is a clip (141 ). The vaso-occlusive (136) additionally has rounded tip (137) as did the device shown in Figure 5.
This device might be assembled in the following manner: First, multiplicity of fibers (143) is included in an open U-shaped clip (141 ). The shank of so the clip is then slid into the interior of coil (139) until the fibers fit snugly against the end of the coil opposite that portion where the head (137) is to be found. The end of the coil (139) is formed of molten fibers from the fiber bundle or of an amount of a settable or molten polymer or the like is applied to form a rounded end (137). The rounded end (137), the coil (139), and the clip (141 ), all cooperate to hold fibers (143) in place.
s Figure 7A shows a side view, cutaway version of the inventive vaso-occlusive device (138) in which the retainer (140) is ovoid and the fibers (142) are introduced into a pair of passageways passing through the periphery of the retainer (140).
Figure 7B shows an end view of the Figure 7A device (138) and io shows the passageways (144 ) in the retainer (140). Although these passageways (144) are shown to be crimped or squeezed to hold the fibers (142) in place, it is acceptable to glue them in the external passageways (144). Passageways (144) are generally parallel to the axis of the retainer.
is Figure 8A and 8B show a variation (150) of the device shown in Figures 7A an 7B. The difference is the multiple number of passageways (144) in the retainer (146).
Figure 9 shows a variation (152) of the invention having generally isolated fibers (154) exterior to the coil component (156). The coil 2o component (156) also contains an interior fiber bundle (158). A soft tip (153) made in any of the ways discussed herein is located at one end of the device (152).
Figure 10 shows a further variation (151 ) of the inventive device which is similar to the Figure 9 variation. The significant difference is that 2s the exterior of the coil component (156) is at least partially covered with a fibrous, typically polymeric, braid (157) in place of the exterior fibers (154) in Figure 9.
Figure 11 shows a longer variation (160) of the inventive device having multiple retainers (128). The fibers (162) are sized and situated in so such a way that a portion of the bundle terminates between a pair of retainers (128). This variation (160) has the benefits of potentially s shielding the retainer (128) from the interior of the delivery catheters during that delivery. A soft tip (161 ) is included. It also provides for enhanced thrombogenicity.
Figure 12 shows a variation of the inventive vaso-occlusive device (166) with a soft tip (161 ) in which multiple retainers (128) are used to hold the fiber bundle (168) in a straight through passage.
In the variations shown in Figures 11 and 12 and in the other multiple retainer variations, and of the retainers, e.g., ovoid, spherical, coil, cylindrical, may be used and they may be mixed, as is discussed below.
Figure 13 shows a multiple retainer (128) variation of the device (170) with soft tip (161 ) in which the outer fibers (172) in the bundle (174) extend outwardly past the outer diameter of the retainer (128). The center fibers in the bundle (174) are straight in this configuration.
Figure 14 shows another multiple retainer configuration (180) of the device. The retainers are a mixture of cylinder (128) and a coil (132). In this variation, the outer fibers (182) of the bundle (184) extend outwardly between the binders (128, 132). This variation of the invention provides a large leading hydraulic surface to the device when introducing the device using fluid pressure delivery.
This device may be delivered using typical pusher techniques and an endovascular catheter as described in the Ritchart et al. patent or using the hydraulic techniques described in Canadian Patent Application No.
2,127,713 by Zenzen et al.
This invention has been described using examples of the preferred embodiments. Obvious variations of the invention within the equivalents of the invention found in the following claims are considered to be within the scope of the invention.
Figure 1 shows in cross section a side view of a generalization of the inventive vaso-occlusive device (100). Figure 1 shows the convention and defines many of the specific terms used herein. The retainer or io binder (102) is so-called because in most variations of the inventions it retains the included fiber bundle (104) located in the passageway (106) located in retainer (102). The retainer (102) has a retainer length (108) which extends along the retainer axis (110) between the furthermost ends of the retainer (102). Similarly, the retainer (102) has a diameter (112) is which is the outer limit of the retainer (102) generally perpendicular to the axis (110). Desirable in this invention are retainers (102) in which the ratio of retainer length (108) to diameter (112) is no more than about two, preferably no more than about one. On at least one end of the retainer is a soft tip (114) which adheres to the retainer (102). The soft tip (114) may 2o be formed by application of heat to the fiber bundles and melting the fibers in the fiber bundle (104) to form a shaped tip. Of course, the tip may be formed by application of other materials (settable glues or caulks such as epoxies) or by melting another polymeric composition onto the tip region. By "soft tip", we mean that the hardness of the tip as measured by 2s accepted procedures (durometers, needle penetration, etc.) is less than the hardness of the helically wound coil itself.
The fiber portion (104) of the device (100) is a multiplicity of fibers having a length (114) which reflects the longest fiber extension in a specific device (100). Desirable to this invention are those structures in 3o which the ratio of the length (114) of the fibers (104) and the soft tip (114) to the retainer length (108) is at least two, more preferably at least five.
s Although the size of the device (100) is dependent upon the specific use to which it is placed, for most endovascular uses, the diameter (112) of retainer (102) typically will be between 0.005 and 0.090 inches. Smaller sizes are desirable because of the intent to use those devices in small, distal arteries. For that indication, a retainer outside diameter (112) of 0.005 to 0.015 inches is preferred.
The length (114) of the fibers are typically in the range of 0.100 inches or more.
The device (100) is typically radio-opaque. Either or both of the retainer (102) and the fibers (104) may be radio-opaque. The retainer (102) may be made of any material suitable for holding onto the fibers.
Typical materials include those metal or alloys selected from the group consisting of various stainless steels, gold, tungsten, platinum, palladium, rhodium, rhenium and alloys thereof. Preferred is an alloy of platinum and tungsten.
Other materials suitable for the retainer (102) include polymeric composition, e.g., adhesives and moldable caulks. Especially preferred are epoxies, urethane, and silicones. Highly desirable as adjuncts to these polymeric compositions are particulate radio-opaque fillers, e.g., powder tantalum, barium carbonate, bismuth oxide, barium sulfate, and the like.
The materials used in the fibers (104) may be thrombogenic material but typically are silk, cotton, polyesters such as the Nylons and polyethylene terephthalate (e.g., DACRON*), polyurethane, polyethylene, etc.
Figure 2 shows a side view, cross section of the inventive device (120) having a generally spherical retainer (122) and a soft end (123). In this variation, the passageway is an opening placed through the center of the retainer (122). The fibers (124) are held in place by, e.g., crimping or squeezing the retainer or by introducing a glue into the interior of the retainer. The fibers (124) are merely placed as tufts in the retainer (122).
*Trade-mark ~2(JU~~~
_i Figure 3 shows a side view cutaway of the device (126) in which the retainer (124) is generally cylindrical in shape. As was the case with the Figure 2 variation, the fibers (124) pass through the center of the retainer (128). A soft end is found at (125).
s Figure 4 shows a side view cutaway of a variation of the device (130) utilizing a coil as the retainer (132). When using high ductility metals in the coil retainer (132), it is sometimes desirable to augment the retainer (132) with a glue or the like to hold the fibers (124) with greater certainty. A soft tip (127)'is included on one end.
Figure 5 shows a side view cutaway of a variation of the device (131 ) utilizing coil (133) as the retainer. In this variation of the device, the fibers (134) do not pass completely through the axis of the retainer coil (133). Instead they are pulled through and are held in place by the coil itself after insertion between turns of the coil. The length of the various Is fibers (134) are much longer than is the length of coil (133). Typical of the use of a coil such as this in which the leading edge of the coil is exposed to the lumen of a blood vessel is the use of a rounded soft tip (135). Soft tip (135) may be made in a variety of different ways. The typical way of making such a tip is to melt a polymeric material onto the coil to form the 2o rounded tip (135). Although the diameter of tip (135) is shown to be relatively the same as that of coil (133), the rounded tip may have a diameter which is larger or smaller than coil (133).
Figure 6 shows still another variation of the vaso-occlusive device (136) utilizing a coil retainer (139). However, in this instance, the coil 2s (139) is used only as a portion of a retainer assembly. The device which directly encloses the fibers (143) is a clip (141 ). The vaso-occlusive (136) additionally has rounded tip (137) as did the device shown in Figure 5.
This device might be assembled in the following manner: First, multiplicity of fibers (143) is included in an open U-shaped clip (141 ). The shank of so the clip is then slid into the interior of coil (139) until the fibers fit snugly against the end of the coil opposite that portion where the head (137) is to be found. The end of the coil (139) is formed of molten fibers from the fiber bundle or of an amount of a settable or molten polymer or the like is applied to form a rounded end (137). The rounded end (137), the coil (139), and the clip (141 ), all cooperate to hold fibers (143) in place.
s Figure 7A shows a side view, cutaway version of the inventive vaso-occlusive device (138) in which the retainer (140) is ovoid and the fibers (142) are introduced into a pair of passageways passing through the periphery of the retainer (140).
Figure 7B shows an end view of the Figure 7A device (138) and io shows the passageways (144 ) in the retainer (140). Although these passageways (144) are shown to be crimped or squeezed to hold the fibers (142) in place, it is acceptable to glue them in the external passageways (144). Passageways (144) are generally parallel to the axis of the retainer.
is Figure 8A and 8B show a variation (150) of the device shown in Figures 7A an 7B. The difference is the multiple number of passageways (144) in the retainer (146).
Figure 9 shows a variation (152) of the invention having generally isolated fibers (154) exterior to the coil component (156). The coil 2o component (156) also contains an interior fiber bundle (158). A soft tip (153) made in any of the ways discussed herein is located at one end of the device (152).
Figure 10 shows a further variation (151 ) of the inventive device which is similar to the Figure 9 variation. The significant difference is that 2s the exterior of the coil component (156) is at least partially covered with a fibrous, typically polymeric, braid (157) in place of the exterior fibers (154) in Figure 9.
Figure 11 shows a longer variation (160) of the inventive device having multiple retainers (128). The fibers (162) are sized and situated in so such a way that a portion of the bundle terminates between a pair of retainers (128). This variation (160) has the benefits of potentially s shielding the retainer (128) from the interior of the delivery catheters during that delivery. A soft tip (161 ) is included. It also provides for enhanced thrombogenicity.
Figure 12 shows a variation of the inventive vaso-occlusive device (166) with a soft tip (161 ) in which multiple retainers (128) are used to hold the fiber bundle (168) in a straight through passage.
In the variations shown in Figures 11 and 12 and in the other multiple retainer variations, and of the retainers, e.g., ovoid, spherical, coil, cylindrical, may be used and they may be mixed, as is discussed below.
Figure 13 shows a multiple retainer (128) variation of the device (170) with soft tip (161 ) in which the outer fibers (172) in the bundle (174) extend outwardly past the outer diameter of the retainer (128). The center fibers in the bundle (174) are straight in this configuration.
Figure 14 shows another multiple retainer configuration (180) of the device. The retainers are a mixture of cylinder (128) and a coil (132). In this variation, the outer fibers (182) of the bundle (184) extend outwardly between the binders (128, 132). This variation of the invention provides a large leading hydraulic surface to the device when introducing the device using fluid pressure delivery.
This device may be delivered using typical pusher techniques and an endovascular catheter as described in the Ritchart et al. patent or using the hydraulic techniques described in Canadian Patent Application No.
2,127,713 by Zenzen et al.
This invention has been described using examples of the preferred embodiments. Obvious variations of the invention within the equivalents of the invention found in the following claims are considered to be within the scope of the invention.
Claims (17)
1. A vaso-occlusive device comprising:
a.) at least one retainer having opposing ends, a retainer axis extending between those ends, an axial length, at least one passageway extending along said axis;
b.) a multiplicity of fibers passing through at least a portion of said at least one passageway; and c.) at least one soft tip adherent to at least one of said retainer opposing ends.
a.) at least one retainer having opposing ends, a retainer axis extending between those ends, an axial length, at least one passageway extending along said axis;
b.) a multiplicity of fibers passing through at least a portion of said at least one passageway; and c.) at least one soft tip adherent to at least one of said retainer opposing ends.
2. The device of Claim 1 wherein a soft tip is adherent to each of said retainer opposing ends.
3. The device of Claim 1 wherein the retainer is radio-opaque.
4. The device of Claim 1 wherein the retainer comprises a material selected from the group consisting of stainless steel, gold, tungsten, platinum, palladium, rhodium, rhenium, and alloys thereof.
5. The device of Claim 1 wherein the retainer comprises a polymeric material.
6. The device of claim 5 wherein the polymeric material comprises an epoxy.
7. The device of Claim 1 wherein the retainer has a shape selected from spheroid, ovoid, and cylindrical.
8. The device of Claim 1 wherein the retainer comprises a coil.
9. The device of Claim 1 wherein the device comprises a multiplicity of retainers.
10. The device of Claim 9 wherein a portion of the fibers terminate between at least two of said multiplicity of retainers.
11. The device of Claim 9 wherein the multiplicity of fibers extend outwardly from the retainer axis between said at least two of said multiplicity of retainers.
12. The device of Claim 1 wherein the retainer has an external region and wherein at least a portion of the exterior region is covered with a braided polymeric covering.
13. The device of Claim 1 wherein the retainer has an external region and wherein at least a portion of the exterior region is covered with polymeric fibers.
14. A vaso-occlusive device comprising:
a.) at least one helical coil having opposing ends, a retainer access between those ends, an axial length, a passageway extending along said access;
b.) a clip having a closed end and arms extending from that closed end, wherein the arms are passed through the retainer passageway from one opposing end to the other, c.) a multiplicity of fibers retained within the closed end of the clip;
and d.) a soft tip adherent to at least one of said helical coil opposing ends.
a.) at least one helical coil having opposing ends, a retainer access between those ends, an axial length, a passageway extending along said access;
b.) a clip having a closed end and arms extending from that closed end, wherein the arms are passed through the retainer passageway from one opposing end to the other, c.) a multiplicity of fibers retained within the closed end of the clip;
and d.) a soft tip adherent to at least one of said helical coil opposing ends.
15. The device of claim 14 wherein the clip is held in place within the retainer coil by the soft tip.
16. The device of claim 14 wherein the retainer is radio-opaque.
17. The device of claim 14 wherein the retainer coil comprises of material selected from the group consisting of stainless steel, gold, tungsten, platinum, palladium, rhodium, rhenium and alloys thereof.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/633,838 US5792154A (en) | 1996-04-10 | 1996-04-10 | Soft-ended fibered micro vaso-occlusive devices |
| US08/633,838 | 1996-04-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2200764A1 CA2200764A1 (en) | 1997-10-10 |
| CA2200764C true CA2200764C (en) | 2000-11-28 |
Family
ID=24541331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002200764A Expired - Fee Related CA2200764C (en) | 1996-04-10 | 1997-03-21 | Soft-ended fibered micro vaso-occlusive devices |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5792154A (en) |
| EP (1) | EP0800791B1 (en) |
| JP (2) | JP3085655B2 (en) |
| AT (1) | ATE244539T1 (en) |
| AU (1) | AU687164B2 (en) |
| CA (1) | CA2200764C (en) |
| DE (1) | DE69723341T2 (en) |
| ES (1) | ES2197304T3 (en) |
| NO (1) | NO971595L (en) |
Families Citing this family (161)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6176240B1 (en) | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
| US6705323B1 (en) | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
| EP0948935B1 (en) * | 1997-10-30 | 2007-09-05 | Kaneka Medix Corporation | Medical implement for depositing implantable device |
| US5911728A (en) * | 1997-11-18 | 1999-06-15 | Cardiothoracic Systems, Inc. | Cannula purse string suture clamping device |
| US6159165A (en) * | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
| US5980550A (en) * | 1998-06-18 | 1999-11-09 | Target Therapeutics, Inc. | Water-soluble coating for bioactive vasoocclusive devices |
| US5935148A (en) * | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
| US5979446A (en) * | 1998-10-22 | 1999-11-09 | Synergyn Technologies, Inc. | Removable fallopian tube plug and associated methods |
| US8016852B2 (en) * | 1998-11-10 | 2011-09-13 | Stryker Corporation | Bioactive components for incorporation with vaso-occlusive members |
| US6187024B1 (en) | 1998-11-10 | 2001-02-13 | Target Therapeutics, Inc. | Bioactive coating for vaso-occlusive devices |
| EP1867300A3 (en) | 1999-06-02 | 2008-02-27 | Sethel Interventional, Inc. | Intracorporeal occlusive device |
| US6280457B1 (en) * | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
| US6559845B1 (en) * | 1999-06-11 | 2003-05-06 | Pulse Entertainment | Three dimensional animation system and method |
| US6709667B1 (en) | 1999-08-23 | 2004-03-23 | Conceptus, Inc. | Deployment actuation system for intrafallopian contraception |
| US6790218B2 (en) * | 1999-12-23 | 2004-09-14 | Swaminathan Jayaraman | Occlusive coil manufacture and delivery |
| US20050187564A1 (en) * | 1999-12-23 | 2005-08-25 | Swaminathan Jayaraman | Occlusive coil manufacturing and delivery |
| US20020151958A1 (en) * | 2000-03-03 | 2002-10-17 | Chuter Timothy A.M. | Large vessel stents and occluders |
| EP1142535B1 (en) * | 2000-04-07 | 2012-10-03 | Collagen Matrix, Inc. | Embolization device |
| US6855154B2 (en) | 2000-08-11 | 2005-02-15 | University Of Louisville Research Foundation, Inc. | Endovascular aneurysm treatment device and method |
| US6589265B1 (en) * | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
| US6585754B2 (en) * | 2001-05-29 | 2003-07-01 | Scimed Life Systems, Inc. | Absorbable implantable vaso-occlusive member |
| EP2319430B1 (en) * | 2001-05-29 | 2013-11-13 | Microvention, Inc. | Vascular embolization device and method of manufacture |
| US20030093111A1 (en) * | 2001-10-26 | 2003-05-15 | Concentric Medical | Device for vaso-occlusion and interventional therapy |
| FR2832307B1 (en) * | 2001-11-19 | 2004-08-27 | Sofradim Production | DEVICE FOR OCCLUSIONING A BODILY CONDUIT, IN PARTICULAR A VARIOUS VEIN |
| US7608058B2 (en) * | 2002-07-23 | 2009-10-27 | Micrus Corporation | Stretch resistant therapeutic device |
| US20050171572A1 (en) * | 2002-07-31 | 2005-08-04 | Microvention, Inc. | Multi-layer coaxial vaso-occlusive device |
| CA2717255C (en) * | 2002-07-31 | 2015-09-29 | Microvention, Inc. | Three element coaxial vaso-occlusive device |
| CN101919722A (en) | 2002-07-31 | 2010-12-22 | 微温森公司 | The vascular occluding device of three-part coaxial |
| CN1671330B (en) * | 2002-07-31 | 2010-05-26 | 微温森公司 | Three-part coaxial vaso-occlusive device |
| AU2003297534A1 (en) * | 2002-12-24 | 2004-07-22 | Ovion, Inc. | Contraceptive device and delivery system |
| US20040153025A1 (en) * | 2003-02-03 | 2004-08-05 | Seifert Paul S. | Systems and methods of de-endothelialization |
| US7744583B2 (en) | 2003-02-03 | 2010-06-29 | Boston Scientific Scimed | Systems and methods of de-endothelialization |
| EP1464369A1 (en) | 2003-04-04 | 2004-10-06 | Theodorus Suibertus Anthonius ROLF | Toy building block, suited screw and tool for screw |
| WO2005000161A2 (en) * | 2003-06-27 | 2005-01-06 | Ovion, Inc. | Methods and devices for occluding body lumens and/or for delivering therapeutic agents |
| DE602004008301T2 (en) * | 2003-07-03 | 2008-05-08 | Cook Inc., Bloomington | CLOSING DEVICE FOR OCKLUDING THE LIQUID FLOW THROUGH A BODY VESSEL |
| US7621937B2 (en) | 2003-12-03 | 2009-11-24 | St. Jude Medical Puerto Rico LC | Vascular sealing device with high surface area sealing plug |
| US20050137568A1 (en) * | 2003-12-17 | 2005-06-23 | Jones Donald K. | Activatable bioactive implantable medical device and method of use |
| US7294123B2 (en) * | 2003-12-17 | 2007-11-13 | Corris Neurovascular, Inc. | Activatable bioactive vascular occlusive device and method of use |
| US7247159B2 (en) * | 2004-04-08 | 2007-07-24 | Cordis Neurovascular, Inc. | Activatable bioactive vascular occlusive device |
| ES2440650T3 (en) * | 2004-05-21 | 2014-01-29 | Covidien Lp | Metallic coils bonded with polymers or synthetic biological or biodegradable fibers for embolization of a body cavity |
| US7879064B2 (en) | 2004-09-22 | 2011-02-01 | Micro Therapeutics, Inc. | Medical implant |
| EP1793743B1 (en) | 2004-09-22 | 2009-11-18 | Dendron GmbH | Micro-spiral implantation device |
| US8795315B2 (en) | 2004-10-06 | 2014-08-05 | Cook Medical Technologies Llc | Emboli capturing device having a coil and method for capturing emboli |
| US8535345B2 (en) * | 2004-10-07 | 2013-09-17 | DePuy Synthes Products, LLC | Vasoocclusive coil with biplex windings to improve mechanical properties |
| US8425550B2 (en) * | 2004-12-01 | 2013-04-23 | Boston Scientific Scimed, Inc. | Embolic coils |
| CN101146484B (en) | 2005-01-25 | 2015-04-08 | 泰科医疗集团有限合伙公司 | Structures for permanent occlusion of a hollow anatomical structure |
| US8221446B2 (en) | 2005-03-15 | 2012-07-17 | Cook Medical Technologies | Embolic protection device |
| US8945169B2 (en) | 2005-03-15 | 2015-02-03 | Cook Medical Technologies Llc | Embolic protection device |
| DE102005019782A1 (en) * | 2005-04-28 | 2006-11-09 | Dendron Gmbh | Device for implantation of occlusion coils with internal securing means |
| US20060271097A1 (en) * | 2005-05-31 | 2006-11-30 | Kamal Ramzipoor | Electrolytically detachable implantable devices |
| US7850708B2 (en) | 2005-06-20 | 2010-12-14 | Cook Incorporated | Embolic protection device having a reticulated body with staggered struts |
| US8109962B2 (en) | 2005-06-20 | 2012-02-07 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
| US7771452B2 (en) | 2005-07-12 | 2010-08-10 | Cook Incorporated | Embolic protection device with a filter bag that disengages from a basket |
| US7766934B2 (en) | 2005-07-12 | 2010-08-03 | Cook Incorporated | Embolic protection device with an integral basket and bag |
| US8187298B2 (en) | 2005-08-04 | 2012-05-29 | Cook Medical Technologies Llc | Embolic protection device having inflatable frame |
| US8377092B2 (en) | 2005-09-16 | 2013-02-19 | Cook Medical Technologies Llc | Embolic protection device |
| JP5063603B2 (en) * | 2005-09-30 | 2012-10-31 | クック メディカル テクノロジーズ エルエルシー | Coated vascular occlusion device |
| US8632562B2 (en) | 2005-10-03 | 2014-01-21 | Cook Medical Technologies Llc | Embolic protection device |
| US8182508B2 (en) | 2005-10-04 | 2012-05-22 | Cook Medical Technologies Llc | Embolic protection device |
| US8252017B2 (en) | 2005-10-18 | 2012-08-28 | Cook Medical Technologies Llc | Invertible filter for embolic protection |
| US8216269B2 (en) | 2005-11-02 | 2012-07-10 | Cook Medical Technologies Llc | Embolic protection device having reduced profile |
| US8152831B2 (en) | 2005-11-17 | 2012-04-10 | Cook Medical Technologies Llc | Foam embolic protection device |
| US8235047B2 (en) * | 2006-03-30 | 2012-08-07 | Conceptus, Inc. | Methods and devices for deployment into a lumen |
| US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
| JP5230602B2 (en) | 2006-04-17 | 2013-07-10 | タイコ ヘルスケア グループ リミテッド パートナーシップ | System and method for mechanically positioning an endovascular implant |
| US9017361B2 (en) | 2006-04-20 | 2015-04-28 | Covidien Lp | Occlusive implant and methods for hollow anatomical structure |
| US7766935B2 (en) | 2006-06-12 | 2010-08-03 | Codman & Shurtleff, Inc. | Modified headpiece for hydraulic coil deployment system |
| US7670353B2 (en) * | 2006-06-12 | 2010-03-02 | Codman & Shurtleff, Inc. | Modified headpiece for hydraulic coil deployment system |
| BRPI0711784B8 (en) | 2006-06-15 | 2021-06-22 | Microvention Inc | embolization device constructed of expandable polymer and its method of preparation |
| US20080046092A1 (en) * | 2006-08-17 | 2008-02-21 | Richard Champion Davis | Coil embolization device with stretch resistance fiber |
| US20080071307A1 (en) | 2006-09-19 | 2008-03-20 | Cook Incorporated | Apparatus and methods for in situ embolic protection |
| US9901434B2 (en) | 2007-02-27 | 2018-02-27 | Cook Medical Technologies Llc | Embolic protection device including a Z-stent waist band |
| CA2679112C (en) * | 2007-03-05 | 2015-08-11 | Boston Scientific Limited | Deploying embolic coils |
| JP5249249B2 (en) | 2007-03-13 | 2013-07-31 | コヴィディエン リミテッド パートナーシップ | Implant including a coil and a stretch resistant member |
| KR20100015521A (en) | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | An implant, a mandrel, and a method of forming an implant |
| US8419748B2 (en) | 2007-09-14 | 2013-04-16 | Cook Medical Technologies Llc | Helical thrombus removal device |
| US9138307B2 (en) | 2007-09-14 | 2015-09-22 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
| US8252018B2 (en) | 2007-09-14 | 2012-08-28 | Cook Medical Technologies Llc | Helical embolic protection device |
| CN101896488A (en) * | 2007-12-17 | 2010-11-24 | 马林克罗特公司 | Prepare the mutter method of salt of normorphine |
| CA2709379C (en) | 2007-12-21 | 2016-08-16 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
| AU2008345596B2 (en) | 2007-12-21 | 2013-09-05 | Microvention, Inc. | A system and method of detecting implant detachment |
| CA2710146C (en) | 2007-12-21 | 2017-03-28 | Microvention, Inc. | System and method for locating detachment zone of a detachable implant |
| US8545573B2 (en) * | 2008-02-12 | 2013-10-01 | Cook Medical Technologies Llc | Spiral occluding device with an occlusion sail |
| DK2265193T3 (en) | 2008-04-21 | 2012-01-23 | Nfocus Neuromedical Inc | Embolic devices with braided ball and delivery systems |
| JP2011519300A (en) | 2008-05-01 | 2011-07-07 | アニュクローズ エルエルシー | Aneurysm occlusion device |
| US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
| US9242026B2 (en) | 2008-06-27 | 2016-01-26 | Sofradim Production | Biosynthetic implant for soft tissue repair |
| CA2732507A1 (en) | 2008-08-06 | 2010-02-11 | Boston Scientific Scimed, Inc. | Vaso-occlusive devices with textured surfaces |
| EP2370237B1 (en) | 2008-12-08 | 2015-12-02 | Jeff Christian | Micro-cutting machine for forming cuts in products |
| US10363389B2 (en) | 2009-04-03 | 2019-07-30 | Scientia Vascular, Llc | Micro-fabricated guidewire devices having varying diameters |
| US11406791B2 (en) | 2009-04-03 | 2022-08-09 | Scientia Vascular, Inc. | Micro-fabricated guidewire devices having varying diameters |
| US8388644B2 (en) | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
| US8701670B2 (en) * | 2009-04-29 | 2014-04-22 | Bayer Essure Inc. | Trackable occlusion device and catheter system |
| US10639396B2 (en) | 2015-06-11 | 2020-05-05 | Microvention, Inc. | Polymers |
| US20100312321A1 (en) * | 2009-06-03 | 2010-12-09 | William Cook Europe Aps | Embolization coil and delivery system |
| JP2013505791A (en) * | 2009-09-24 | 2013-02-21 | マイクロベンション インコーポレイテッド | Injectable hydrogel fiber for medical use |
| KR101745748B1 (en) | 2009-10-26 | 2017-06-12 | 마이크로벤션, 인코포레이티드 | Embolization device constructed from expansile polymer |
| US8906057B2 (en) | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
| CN102740799A (en) | 2010-01-28 | 2012-10-17 | 泰科保健集团有限合伙公司 | Vascular remodeling device |
| WO2011130081A1 (en) | 2010-04-14 | 2011-10-20 | Microvention, Inc. | Implant delivery device |
| US9220506B2 (en) | 2010-06-16 | 2015-12-29 | DePuy Synthes Products, Inc. | Occlusive device with stretch resistant member and anchor filament |
| US8425548B2 (en) | 2010-07-01 | 2013-04-23 | Aneaclose LLC | Occluding member expansion and then stent expansion for aneurysm treatment |
| WO2012061017A1 (en) * | 2010-10-25 | 2012-05-10 | Boston Scientific Scimed, Inc. | Fibrous containment for hemostasis plug |
| AU2012214240B2 (en) | 2011-02-11 | 2015-03-12 | Covidien Lp | Two-stage deployment aneurysm embolization devices |
| FR2972626B1 (en) | 2011-03-16 | 2014-04-11 | Sofradim Production | PROSTHETIC COMPRISING A THREE-DIMENSIONAL KNIT AND ADJUSTED |
| US20120245674A1 (en) | 2011-03-25 | 2012-09-27 | Tyco Healthcare Group Lp | Vascular remodeling device |
| US10398444B2 (en) | 2011-03-30 | 2019-09-03 | Noha, Llc | Advanced endovascular clip and method of using same |
| US10028745B2 (en) | 2011-03-30 | 2018-07-24 | Noha, Llc | Advanced endovascular clip and method of using same |
| US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
| US9138232B2 (en) | 2011-05-24 | 2015-09-22 | Aneuclose Llc | Aneurysm occlusion by rotational dispensation of mass |
| FR2977790B1 (en) | 2011-07-13 | 2013-07-19 | Sofradim Production | PROSTHETIC FOR UMBILIC HERNIA |
| FR2977789B1 (en) | 2011-07-13 | 2013-07-19 | Sofradim Production | PROSTHETIC FOR UMBILIC HERNIA |
| US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
| US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
| FR2985170B1 (en) | 2011-12-29 | 2014-01-24 | Sofradim Production | PROSTHESIS FOR INGUINAL HERNIA |
| CN104379070B (en) * | 2012-01-17 | 2017-08-08 | 内形有限公司 | For vascular or the plugging device of biological lumen |
| US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
| WO2013119332A2 (en) | 2012-02-09 | 2013-08-15 | Stout Medical Group, L.P. | Embolic device and methods of use |
| US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
| WO2013158781A1 (en) | 2012-04-18 | 2013-10-24 | Microvention, Inc. | Embolic devices |
| FR2994185B1 (en) | 2012-08-02 | 2015-07-31 | Sofradim Production | PROCESS FOR THE PREPARATION OF A POROUS CHITOSAN LAYER |
| FR2995779B1 (en) | 2012-09-25 | 2015-09-25 | Sofradim Production | PROSTHETIC COMPRISING A TREILLIS AND A MEANS OF CONSOLIDATION |
| FR2995788B1 (en) | 2012-09-25 | 2014-09-26 | Sofradim Production | HEMOSTATIC PATCH AND PREPARATION METHOD |
| US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
| US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
| US9119948B2 (en) | 2013-02-20 | 2015-09-01 | Covidien Lp | Occlusive implants for hollow anatomical structures, delivery systems, and related methods |
| US9848882B2 (en) * | 2013-03-08 | 2017-12-26 | Scientia Vascular, Llc | Micro-fabricated embolic devices |
| US9192389B2 (en) | 2013-03-13 | 2015-11-24 | Cook Medical Technologies Llc | Occluding device and method of manufacturing occluding devices |
| US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
| EP3000406A1 (en) | 2013-03-14 | 2016-03-30 | Incumedx Inc. | Implants and methods of manufacturing the same |
| CN105142545B (en) | 2013-03-15 | 2018-04-06 | 柯惠有限合伙公司 | Locking device |
| WO2014145005A2 (en) * | 2013-03-15 | 2014-09-18 | Covidien Lp | Occlusive device |
| US20140330299A1 (en) * | 2013-05-06 | 2014-11-06 | Sequent Medical, Inc. | Embolic occlusion device and method |
| WO2015015314A2 (en) | 2013-07-31 | 2015-02-05 | EMBA Medical Limited | Methods and devices for endovascular embolization |
| US10010328B2 (en) | 2013-07-31 | 2018-07-03 | NeuVT Limited | Endovascular occlusion device with hemodynamically enhanced sealing and anchoring |
| WO2015153996A1 (en) | 2014-04-03 | 2015-10-08 | Micro Vention, Inc. | Embolic devices |
| US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
| US10092663B2 (en) | 2014-04-29 | 2018-10-09 | Terumo Corporation | Polymers |
| JP6599361B2 (en) | 2014-04-29 | 2019-10-30 | マイクロベンション インコーポレイテッド | Polymer containing an active agent |
| US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
| WO2015184075A1 (en) | 2014-05-28 | 2015-12-03 | Stryker European Holdings I, Llc | Vaso-occlusive devices and methods of use |
| JP6601880B2 (en) * | 2014-07-25 | 2019-11-06 | インキュメデックス インコーポレイテッド | Coated embolic coil |
| EP3059255B1 (en) | 2015-02-17 | 2020-05-13 | Sofradim Production | Method for preparing a chitosan-based matrix comprising a fiber reinforcement member |
| DE202015102060U1 (en) * | 2015-04-24 | 2016-07-27 | Pfm Medical Ag | A medical implant for occluding a defect opening, vessel, organ passage, or other opening in a human or animal body |
| EP3085337B1 (en) | 2015-04-24 | 2022-09-14 | Sofradim Production | Prosthesis for supporting a breast structure |
| US10159490B2 (en) | 2015-05-08 | 2018-12-25 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
| ES2676072T3 (en) | 2015-06-19 | 2018-07-16 | Sofradim Production | Synthetic prosthesis comprising a knitted fabric and a non-porous film and method of forming it |
| US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
| US11090055B2 (en) | 2015-10-30 | 2021-08-17 | Incumedx Inc. | Devices and methods for delivering an implant to a vascular disorder |
| US10052108B2 (en) | 2015-10-30 | 2018-08-21 | Incumedx, Inc. | Devices and methods for delivering an implant to a vascular disorder |
| EP3195830B1 (en) | 2016-01-25 | 2020-11-18 | Sofradim Production | Prosthesis for hernia repair |
| US11207502B2 (en) | 2016-07-18 | 2021-12-28 | Scientia Vascular, Llc | Guidewire devices having shapeable tips and bypass cuts |
| US11052228B2 (en) | 2016-07-18 | 2021-07-06 | Scientia Vascular, Llc | Guidewire devices having shapeable tips and bypass cuts |
| US10821268B2 (en) | 2016-09-14 | 2020-11-03 | Scientia Vascular, Llc | Integrated coil vascular devices |
| EP3312325B1 (en) | 2016-10-21 | 2021-09-22 | Sofradim Production | Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained |
| US11452541B2 (en) | 2016-12-22 | 2022-09-27 | Scientia Vascular, Inc. | Intravascular device having a selectively deflectable tip |
| EP3398554A1 (en) | 2017-05-02 | 2018-11-07 | Sofradim Production | Prosthesis for inguinal hernia repair |
| ES2966345T3 (en) | 2017-05-26 | 2024-04-22 | Scientia Vascular Inc | Microfabricated medical device with a non-helical cutting arrangement |
| US11305095B2 (en) | 2018-02-22 | 2022-04-19 | Scientia Vascular, Llc | Microfabricated catheter having an intermediate preferred bending section |
| EP3806754A1 (en) * | 2019-04-18 | 2021-04-21 | Clearstream Technologies Limited | Embolization devices and methods of manufacturing the same |
| TR202015642A2 (en) * | 2020-10-01 | 2020-10-21 | Gaziantep Ueniversitesi Rektoerluegue | VASCULAR CLAMP |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3687129A (en) * | 1970-10-02 | 1972-08-29 | Abcor Inc | Contraceptive device and method of employing same |
| FR2608418B1 (en) * | 1986-12-18 | 1992-07-31 | Pieronne Alain | DEVICE FOR PROVIDING THE OBSTRUCTION OF A NATURAL CHANNEL SUCH AS AN ARTERY IN PARTICULAR IN A PREDETERMINED AREA |
| US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
| FR2641692A1 (en) * | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
| US5095917A (en) * | 1990-01-19 | 1992-03-17 | Vancaillie Thierry G | Transuterine sterilization apparatus and method |
| JPH04312454A (en) * | 1991-04-11 | 1992-11-04 | Olympus Optical Co Ltd | Organism pipe clogging tool |
| US5226911A (en) * | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
| US5304194A (en) * | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
| FR2694699B1 (en) * | 1992-08-11 | 1994-11-04 | Vascor Sarl | Blood filter and its introduction device. |
| US5443478A (en) * | 1992-09-02 | 1995-08-22 | Board Of Regents, The University Of Texas System | Multi-element intravascular occlusion device |
| US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
| US5382260A (en) * | 1992-10-30 | 1995-01-17 | Interventional Therapeutics Corp. | Embolization device and apparatus including an introducer cartridge and method for delivering the same |
| US5690666A (en) * | 1992-11-18 | 1997-11-25 | Target Therapeutics, Inc. | Ultrasoft embolism coils and process for using them |
| US5573547A (en) * | 1993-10-19 | 1996-11-12 | Leveen; Harry H. | Brush fixation method for attachment of tissues and occlusion of blood vessels |
| US5582619A (en) * | 1995-06-30 | 1996-12-10 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils |
-
1996
- 1996-04-10 US US08/633,838 patent/US5792154A/en not_active Expired - Lifetime
-
1997
- 1997-03-21 CA CA002200764A patent/CA2200764C/en not_active Expired - Fee Related
- 1997-03-25 AU AU16504/97A patent/AU687164B2/en not_active Ceased
- 1997-04-04 ES ES97302336T patent/ES2197304T3/en not_active Expired - Lifetime
- 1997-04-04 JP JP09086950A patent/JP3085655B2/en not_active Expired - Fee Related
- 1997-04-04 DE DE69723341T patent/DE69723341T2/en not_active Revoked
- 1997-04-04 EP EP97302336A patent/EP0800791B1/en not_active Revoked
- 1997-04-04 AT AT97302336T patent/ATE244539T1/en not_active IP Right Cessation
- 1997-04-08 NO NO971595A patent/NO971595L/en not_active Application Discontinuation
-
1998
- 1998-03-13 US US09/042,416 patent/US5976162A/en not_active Expired - Lifetime
-
2000
- 2000-03-15 JP JP2000073179A patent/JP3310256B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3310256B2 (en) | 2002-08-05 |
| EP0800791A1 (en) | 1997-10-15 |
| AU687164B2 (en) | 1998-02-19 |
| CA2200764A1 (en) | 1997-10-10 |
| NO971595D0 (en) | 1997-04-08 |
| US5976162A (en) | 1999-11-02 |
| EP0800791B1 (en) | 2003-07-09 |
| JP3085655B2 (en) | 2000-09-11 |
| ES2197304T3 (en) | 2004-01-01 |
| DE69723341T2 (en) | 2004-06-03 |
| AU1650497A (en) | 1997-10-16 |
| ATE244539T1 (en) | 2003-07-15 |
| JPH1024039A (en) | 1998-01-27 |
| JP2000271131A (en) | 2000-10-03 |
| US5792154A (en) | 1998-08-11 |
| DE69723341D1 (en) | 2003-08-14 |
| NO971595L (en) | 1997-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2200764C (en) | Soft-ended fibered micro vaso-occlusive devices | |
| CA2192105C (en) | Fibered micro vaso-occlusive devices | |
| US5957948A (en) | Three dimensional in-filling vaso-occlusive coils | |
| US5733329A (en) | Vaso-occlusive coil with conical end | |
| US7645292B2 (en) | Vaso-occlusive devices with in-situ stiffening elements | |
| US5639277A (en) | Embolic coils with offset helical and twisted helical shapes | |
| US6299627B1 (en) | Water-soluble coating for bioactive vasoocclusive devices | |
| AU681073B2 (en) | Large diameter vasoocclusion coil | |
| JP4783927B2 (en) | Vascular occlusion coil having selectively planarized regions | |
| US20030004568A1 (en) | Coated combination vaso-occlusive device | |
| US20030004533A1 (en) | Bioactive polymer vaso-occlusive device | |
| JP2004511293A (en) | Non-overlapping spherical three-dimensional vaso-occlusive coil | |
| CA2162620A1 (en) | Microcatheter-less coil delivery device | |
| US20090163945A1 (en) | Polymeric slotted tube coils |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20150323 |